Key Financial Data Of Group

ONO PHARMACEUTICAL CO., LTD. - Filing #7715236

Concept 2018-04-01 to
2018-12-31
2018-10-01 to
2018-12-31
As at
2018-12-31
2017-04-01 to
2018-03-31
As at
2018-03-31
2017-04-01 to
2017-12-31
As at
2017-12-31
2017-10-01 to
2017-12-31
Key financial data of group
Business results of group
Revenue
223,197,000,000 JPY
78,802,000,000 JPY
261,836,000,000 JPY
200,570,000,000 JPY
79,125,000,000 JPY
Profit (loss) before tax
55,234,000,000 JPY
63,922,000,000 JPY
55,333,000,000 JPY
Profit (loss), attributable to owners of parent
43,133,000,000 JPY
14,288,000,000 JPY
50,284,000,000 JPY
41,439,000,000 JPY
20,229,000,000 JPY
Comprehensive income
37,419,000,000 JPY
67,607,000,000 JPY
65,744,000,000 JPY
Equity attributable to owners of parent
544,015,000,000 JPY
524,390,000,000 JPY
522,528,000,000 JPY
Total assets
629,398,000,000 JPY
609,226,000,000 JPY
596,208,000,000 JPY
Basic earnings (loss) per share
83.90
27.79
97.00
79.74
39.35
Diluted earnings (loss) per share
83.89
27.79
96.99
79.74
39.34
Ratio of owners' equity to gross assets
0.864 xbrli:pure
0.861 xbrli:pure
0.876 xbrli:pure
Cash flows from (used in) operating activities
43,005,000,000 JPY
15,727,000,000 JPY
-8,537,000,000 JPY
Cash flows from (used in) investing activities
-7,106,000,000 JPY
-34,189,000,000 JPY
-36,625,000,000 JPY
Cash flows from (used in) financing activities
-21,418,000,000 JPY
-62,549,000,000 JPY
-61,595,000,000 JPY
Cash and cash equivalents
79,720,000,000 JPY
65,273,000,000 JPY
39,708,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.